Researchers at Sandia have created a platform for
discovering, designing and engineering novel antibody
countermeasures for emerging viruses. This new process of screening
for nanobodies that “neutralize” or disable the virus represents a
faster, more effective approach to developing nanobody therapies
that prevent or treat viral infection.